Why Medibank and NIB shares might be in the buy zone

Are ASX private health shares Medibank Private Ltd (ASX: MPL) and NIB Holdings Ltd (ASX: NHF) in the buy zone today?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are ASX private health insurers Medibank Private Ltd (ASX: MPL) and NIB Holdings Limited (ASX: NHF) shares in the buy zone today?

A lot of negative coverage of the private health insurance business has been dominating the news lately.

Take this report from ABC – which declares the private health business model to be in a 'death spiral' from increasing costs and more and more people abandoning coverage (especially the young). According to the report, just 44% of Australians now have basic hospital cover.

How does private health insurance work?

Like any insurance, private health works by collecting premiums from all customers and paying out those who make legitimate claims. The more people in the fund, the less the average premium should be (in theory at least).

The problem for private health insurers like Medibank Private and NIB is that this particular industry is heavily regulated by the government. Sure, on one hand, there are tax incentives such as the Medicare Levy Surcharge and Private Health Insurance Rebate that work to encourage customers to take out private health insurance.

But on the other, there are rules that limit these companies to how much they can raise their premiums every year as well as how much they are allowed to charge their customers (for example, older members as opposed to younger members).

I'm not disputing the social merits of these policies here, but it can't be argued they're good for these companies' bottom lines.

So why are Medibank and NIB in the buy zone then?

Well, firstly the share prices of Medibank and NIB have taken a hit today. Medibank reported its half-year earnings this morning and it wasn't a pretty picture. Earnings per share were down 14.3%. The company kept its dividend steady but is now paying out 88% of earnings to cover it – up from 67% last year. That's not a good sign. In response, the Medibank share price is under $3 at the time of writing – down 1.85% to $2.92.

But here's why this might be a buying opportunity.

In my opinion, the government isn't going to let the private health insurance business model collapse. Private health takes a lot of pressure off the publicly-funded Medicare program. With our ageing population only going to get worse in the next decade or two, the government can't afford to take up the slack and would much rather the private sector do the heavy lifting.

So, I would expect some reforms coming down the road that will increase the viability of the current private health model – which in turn should increase the value of the businesses that run it.

This is just my opinion, but I don't see it going any other way.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »